Test from Staging

Jan 11, 2012

2025 11 10 Psma Pet Phase Ii Trial Thumbnail

PSMA-PET effective for initial staging of prostate cancer

November 14, 2025

Nuclear Medicine Gamma Camera 400 (1)

Nuclear medicine societies launch theranostics consortium

October 31, 2025

Artificial Intelligence Ai Hand 400

LLMs rapidly evolving in nuclear medicine

October 27, 2025

Dedicated breast F-18 FDG PET/MRI exam pre- (A, D, G), mid- (B, E, H), and post-NAC (C, F, I) of a 41-year-old patient diagnosed with a triple negative (TN), grade 2, invasive carcinoma. The SUVmax values of the primary tumor were 14.68 pre-NAC, 1.69 mid-NAC, and 1.87 post-NAC, while SER values were 1.19, 0.52, and 0.63, respectively. Figure courtesy of Melissa Lenaerts, PhD, Dr. Thiemo van Nijnatten, PhD, et al and presented at EUSOBI 2025.

PET/MRI begins to deliver in breast cancer

October 23, 2025

PSMA-PET effective for initial staging of prostate cancer

Upfront PSMA-PET/CT has a significant impact on treatment decision-making in men with suspected disease.

November 14, 2025

2025 11 10 Psma Pet Phase Ii Trial Thumbnail

Nuclear medicine societies launch theranostics consortium

By AuntMinnieEurope.com staff writers

Four nuclear medicine societies have collaborated to establish a consortium that seeks to advance theranostics care.

October 31, 2025

Nuclear Medicine Gamma Camera 400 (1)

LLMs rapidly evolving in nuclear medicine

Large language models (LLMs) are widely used to handle the large volume of text data generated in nuclear medicine.

October 27, 2025

Artificial Intelligence Ai Hand 400

PET/MRI begins to deliver in breast cancer

The clinical role of PET/MRI is evolving rapidly in breast cancer, according to two studies presented at the European Society of Breast Imaging annual meeting.

October 23, 2025

Dedicated breast F-18 FDG PET/MRI exam pre- (A, D, G), mid- (B, E, H), and post-NAC (C, F, I) of a 41-year-old patient diagnosed with a triple negative (TN), grade 2, invasive carcinoma. The SUVmax values of the primary tumor were 14.68 pre-NAC, 1.69 mid-NAC, and 1.87 post-NAC, while SER values were 1.19, 0.52, and 0.63, respectively. Figure courtesy of Melissa Lenaerts, PhD, Dr. Thiemo van Nijnatten, PhD, et al and presented at EUSOBI 2025.

EUSOBI: Positron emission mammography demonstrates worth

By Edna Astbury-Ward, PhD

Positron emission mammography is proving useful in the presurgical assessment of invasive lobular carcinoma, researchers reported at the European Society of Breast Imaging (EUSOBI) annual meeting.

October 22, 2025

A 399 Fig 2 Pem Vs Cesm E Poster Eusobi 2025 Deabes Thumbnail

Amyloid PET can track patterns of neurodegeneration

By Maryam Payne

Early perfusion amyloid-PET shows potential for diagnosing and monitoring neurodegenerative disease and has possible advantages over FDG-PET scanning.

October 22, 2025

2025 10 20 Eanm Early Perfusion Imaging Fig1 Thumbnail

PSMA-PET/CT may replace NaF-PET/CT in advanced prostate cancer

Replacing F-18 sodium fluoride (NaF) PET/CT with F-18 PSMA PET/CT can improve treatment for men with newly diagnosed prostate cancer.

October 13, 2025

2025 10 09 Jnumed Psma Pet Vs Na F Pet Thumbnail

Will AI lead to merger of radiology and pathology?

By Edna Astbury-Ward, PhD

A strategic merger of radiology and pathology into a unified specialty is vital, two experts have warned in an 8 October commentary in European Journal of Radiology AI.

October 9, 2025

Glowing Neon Skeleton Nervous System Adobe Yuliia

GLP-1 drugs may confound PET/CT imaging findings

By AuntMinnieEurope.com staff writers

GLP-1 receptor agonists may affect the interpretation of oncological FDG PET/CT scans, according to research presented at the annual meeting of the European Association of Nuclear Medicine.

October 8, 2025

Semaglutide Injection Pen

GEHC, Erasmus MC to collaborate on PET/CT

By AuntMinnieEurope.com staff writers

GE HealthCare (GEHC) and Erasmus MC in Rotterdam, the Netherlands, are collaborating on evaluating next-generation total body PET/CT technology.

October 7, 2025

Erasmus Mc Resized

PET/CT links metabolic activity to aggressive endometrial cancer

By AuntMinnieEurope.com staff writers

Aggressive endometrial cancer may drive the high metabolic activity of visceral fat, Norwegian researchers reported in Barcelona at the 40th anniversary meeting of the European Association of Nuclear Medicine.

October 5, 2025

Eanm 2025 Congress Poster

French AI startup adds PSMA model to PET/CT AI assistant

By AuntMinnieEurope.com staff writers

Nuclear medicine AI start-up Paire has added a prostate-specific membrane antigen (PSMA) model to its PET/CT AI assistant, Pionus.

October 2, 2025

Page 1 of 123